Jenburkt Pharma Closes Trading Window for Insider Trading

Jenburkt Pharmaceuticals Limited has announced the closure of its trading window for all designated persons, insiders, and connected individuals, including their relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain shut from October 1, 2026, until 48 hours after the dissemination of the standalone unaudited financial results for the quarter and half-year ending September 30, 2026. The company will separately inform the exchange about the board meeting schedule to consider these financial results.